{"id":"W2122397603","doi":"10.1007/978-1-60761-524-8_10","title":"Epidermal Growth Factor Receptor Inhibitors in the Treatment of Non-small Cell Lung Cancer","year":2010,"lang":"en","type":"book-chapter","venue":"Lung Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Erlotinib; Gefitinib; Cetuximab; Medicine; Epidermal growth factor receptor; Docetaxel; Lung cancer; Oncology; Bevacizumab; Erlotinib Hydrochloride; Internal medicine; Chemotherapy; Clinical trial; EGFR inhibitors; Monoclonal antibody; Tyrosine kinase; Pharmacology; Cancer research; Cancer; Immunology; Receptor; Antibody","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00006232126,0.0006053624,0.0008820579,0.0002341809,0.0001006617,0.00002326732,0.0001869862,0.0004917501,0.002481849],"category_scores_gemma":[0.00000633833,0.0003904519,0.0004044407,0.00009753129,0.0001284292,0.00006556862,0.00002478071,0.0005033016,0.00001665282],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001511132,"about_ca_system_score_gemma":0.001106798,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005582024,"about_ca_topic_score_gemma":0.003580868,"domain_scores_codex":[0.9979428,0.00002494624,0.0006071378,0.0005831835,0.0004163131,0.0004256084],"domain_scores_gemma":[0.9985228,0.0001277551,0.0004197896,0.00056465,0.0002028699,0.0001621872],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002530173,0.006288968,0.5410873,0.0128321,0.01559454,0.001033919,0.1074009,0.0001825434,0.02461016,0.005048384,0.1357909,0.1476001],"study_design_scores_gemma":[0.0164203,0.001971197,0.02948056,0.0056537,0.01150438,0.00002531729,0.0003563721,0.0001931809,0.03047373,0.0002241635,0.9017305,0.001966552],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"other","genre_gemma":"other","genre_scores_codex":[0.2683507,0.1305626,0.0000678889,0.008197107,0.01035943,0.01547906,0.005804701,0.000195995,0.5609825],"genre_scores_gemma":[0.2588499,0.04850296,0.000849482,0.001600734,0.005381537,0.00375069,0.0007812717,0.000468521,0.6798149],"genre_candidate":"other","genre_consensus":"other","teacher_disagreement_score":0.7659396,"threshold_uncertainty_score":0.9998547,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01444095198798569,"score_gpt":0.3087034878413512,"score_spread":0.2942625358533655,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}